|
|
Volumn 8, Issue 7, 1999, Pages 1017-1030
|
|
Selenium-based drug design: Rationale and therapeutic potential
|
|
Author keywords
Ebselen; Phenylaminoalkyl selenides; Selenium based drug design; Selenoenzymes; Selenoproteins; Therapeutic agents; Thioredoxin reductase inhibitors
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
EBSELEN;
FREE RADICAL;
GLUTATHIONE PEROXIDASE;
IMMUNOSUPPRESSIVE AGENT;
ORGANOSELENIUM DERIVATIVE;
SELENAZOFURIN;
SELENIUM;
SELENIUM DERIVATIVE;
SELENOCYSTEINE;
SELENOPROTEIN;
THIOREDOXIN REDUCTASE;
THYROXINE DEIODINASE;
TIAZOFURIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTHRITIS;
DIET SUPPLEMENTATION;
DRUG DESIGN;
ENZYME ACTIVE SITE;
HEART DISEASE;
HUMAN;
METABOLISM;
NONHUMAN;
OXIDATIVE STRESS;
PROSTATE CANCER;
REVIEW;
|
|
EID: 0032805978
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.8.7.1017 Document Type: Review |
|
Times cited : (51)
|
|
References (100)
|
